Ligand Pharmaceuticals Incorporated financial statements, including revenue, expenses, profit, and loss

The total revenue of LGND for the last quarter is 28.10 M USD, and it's 14.50% lower compared to the previous quarter. The net income of Q4 23 is 18.19 M USD.